HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression.

Abstract
It is now well established that an array of CC and CXC chemokine receptors, in association with the CD4 molecule, can interact with the HIV-1 gp120 protein to facilitate viral fusion. A 32bp deletion in the CC chemokine receptor CCR5, the major M-tropic viral co-receptor, provides considerable protection against HIV-1 transmission and has been associated with a delay in disease progression. The effects of the Delta32 allele appear to be mediated through the phenotype of CCR5 expression as opposed to genotype. Here we discuss the potential effects that the Delta32 allele and other polymorphisms in the chemokine receptor repertoire may have on both HIV-1 transmission and disease progression.
AuthorsW A Paxton, S Kang
JournalSeminars in immunology (Semin Immunol) Vol. 10 Issue 3 Pg. 187-94 (Jun 1998) ISSN: 1044-5323 [Print] England
PMID9653045 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
CopyrightCopyright 1998 Academic Press.
Chemical References
  • Receptors, Chemokine
Topics
  • Alleles
  • Genetic Predisposition to Disease
  • HIV Infections (genetics, immunology, physiopathology)
  • HIV-1
  • Humans
  • Polymorphism, Genetic
  • Receptors, Chemokine (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: